Brief: Aileron Therapeutics Reports Q2 2022 Results
15/08/2022 22:03
Aug 15 (Reuters) - Aileron Therapeutics Inc ALRN.O :
* AILERON THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND BUSINESS HIGHLIGHTS
* AILERON THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.09
* AILERON THERAPEUTICS INC - QTRLY CASH, CASH EQUIVALENTS,
AND
INVESTMENTS WERE $32.4 MILLION
Source text for Eikon: ID:nGNX7FWd8w
Further company coverage: ALRN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rein Therapeutics
See all newsBrief: Rein Therapeutics Receives U.S. FDA Fast Track Designation For Lti-03 In Idiopathic Pulmonary Fibrosis
Rein Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Rein Therapeutics Q2 net loss narrows on lower R&D spending
Rein Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Rein Therapeutics Announces Closing Of $57.5 Million Underwritten Public Offering